Figure 9
From: Prognostic implications of N6-methyladenosine RNA regulators in breast cancer
YTHDF1 functional verification. (A,B) Expression levels of YTHDF1 and its targets after YTHDF1 knockdown. (C,D) YTHDF1 and KIAA1429 expression levels in BC and adjacent breast tissue; (E,F) YTHDF1 and KIAA1429 expression levels in high and low immunity group. High imm stands for high immunity group. Low imm stands for low immunity group. (G) The expression of YTHDF1 in pan-cancer. Blue represents normal tissue and red represents cancer tissue. (H,I) Correlation between YTHDF1 expression and microsatellite instability (H) and tumour mutation burden (I) in pan-cancer. (J, K) Relationship between the DNA (J) and RNA (K) stemness scores and m6A regulators expression levels in pan-cancer. (L,M) Correlation between YTHDF1 expression and immune cell infiltration in pan-cancer. (L) Mast cells resting in bladder urothelial carcinoma. (M) Dendritic cells resting in breast invasive carcinoma.
